PFBT
RVMD icon

Parkside Financial Bank & Trust’s Revolution Medicines RVMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5K Buy
36
+18
+100% +$1.82K ﹤0.01% 1933
2025
Q4 		$1.43K Buy
18
+16
+800% +$1.05K ﹤0.01% 2216
2025
Q3 		$94 Sell
2
-32
-94% -$1.25K ﹤0.01% 2679
2025
Q2 		$1.25K Sell
34
-36
-51% -$1.38K ﹤0.01% 2171
2025
Q1 		$2.48K Buy
+70
New +$2.84K ﹤0.01% 1826

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parkside Financial Bank & Trust's RVMD Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Revolution Medicines (RVMD) stake by 100% in Q1 2026, buying an estimated $1.82K and bringing the position to 36 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

Parkside Financial Bank & Trust first reported a position in RVMD in Q1 2025 and has held it in 5 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Parkside Financial Bank & Trust held 36 shares of Revolution Medicines worth $3.5K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 18 Revolution Medicines shares in Q1 2026, an estimated $1.82K.
  • Revolution Medicines made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1933 holding.
  • Parkside Financial Bank & Trust first reported a position in Revolution Medicines in Q1 2025 and has held it in 5 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.